drug
as of 2026-07-01ANAVEX3-71 oral capsules
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Anavex Life Sciences Corp.
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
A Study of ANAVEX3-71 in Adults With Schizophrenia
NCT06245213Phase 2Active Not Recruiting
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication